Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Binex Co., Ltd. (053030:KRX), powered by AI.
Binex Co., Ltd. is currently trading at ₩8,200. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Binex Co., Ltd. on Alpha Lenz.
Binex Co., Ltd.'s P/E ratio is -83.1.
“Binex Co., Ltd. trades at a P/E of -83.1 (undervalued) with modest ROE of -1.8%.”
Ask for details →Binex Co., Ltd. is a distinguished entity in the pharmaceutical industry, primarily engaged in the manufacture and distribution of biopharmaceutical products. The company focuses on the production of a wide range of medications and therapies, catering to various health needs. With its advanced technological capabilities and innovative research, Binex stands out for its contributions to healthcare improvements and therapeutic solutions. The company operates on a global scale, impacting sectors such as healthcare providers, pharmacies, and pharmaceutical retailers. Binex Co., Ltd. plays a crucial role in the financial markets by being a part of the pharmaceutical supply chain, influencing the availability and accessibility of essential medicines. Its dedication to innovation and quality manufacturing processes positions it as a key player in the biopharmaceutical field, contributing significantly to advancements in medical treatment and patient care.
“Binex Co., Ltd. trades at a P/E of -83.1 (undervalued) with modest ROE of -1.8%.”
Ask for details →Binex Co., Ltd. (ticker: 053030) is a company listed on KRX in the Common Stock sector (Common Stock). Market cap is $268.0B.
The current price is ₩8,200 with a P/E ratio of -83.08x and P/B of 1.43x.
ROE is -1.75% and operating margin is -2.69%. Annual revenue is $168.5B.